US2002009748A1PendingUtilityA1

Nucleobase heterocyclic combinatorialization

Priority: Jun 30, 1997Filed: May 13, 1998Published: Jan 24, 2002
Est. expiryJun 30, 2017(expired)· nominal 20-yr term from priority
C07H 19/16C40B 40/00C07D 473/00
34
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Mixtures of chemical compounds are provided having antibacterial and other utility. The mixtures are formed, preferably in solution phase, from the reaction of a purine or pyrimiding heterocyclic scaffold with a set of related chemical substituients, optionally through employment of a tether moiety. Libraries formed in accordance with the invention have utility per se and are articles of commerce. They can be used to screen for pesticides, drugs and other biologically active compounds.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A mixture comprising at least six chemical compounds each having a common purine or pyrimidine heterocyclic scaffold, said scaffold having at least two functionalizable atoms, said scaffold being substituted at at least one of said functionalizable atoms with a set of at least six different chemical substituients optionally connected to said heterocyclic scaffold by a tether moiety.  
     
     
         2 . The mixture of  claim 1  comprising at least ten chemical compounds.  
     
     
         3 . The mixture of  claim 1  comprising at least fifteen chemical compounds.  
     
     
         4 . The mixture of  claim 1  wherein said chemical compounds are within 20 mole percent of equimolarity in said mixture.  
     
     
         5 . The mixture of  claim 1  wherein said heterocyclic scaffold has at least three functionalizable atoms.  
     
     
         6 . The mixture of  claim 1  wherein said tether moiety is the same for each chemical substituient.  
     
     
         7 . The mixture of  claim 1  wherein at least one of the functionalizable atoms on said heterocyclic scaffold is nucleophilic.  
     
     
         8 . The mixture of  claim 1  wherein said tether moiety bears at least one functionalizable atom.  
     
     
         9 . The mixture of  claim 8  wherein at least one functionalizable atom on said tether moiety is nucleophilic.  
     
     
         10 . The mixture of  claim 8  wherein the at least one functionalizable atom on the tether moiety is substituted with a set of chemical substituients.  
     
     
         11 . The mixture of  claim 8  wherein the set of chemical substituients on the tether moiety are electrophilic.  
     
     
         12 . The mixture of  claim 1  wherein said chemical substituients are electrophilic.  
     
     
         13 . The mixture of  claim 1  wherein at least one functionalizable atom of said heterocyclic scaffold is chemically blocked.  
     
     
         14 . The mixture of  claim 1  wherein said chemical compounds are synthesized simultaneously in solution phase.  
     
     
         15 . The mixture of  claim 1  wherein said chemical compounds are synthesized simultaneously in solution phase through an interative synthetic process.  
     
     
         16 . The mixture of  claim 1  wherein said process comprises the blocking and deblocking of at least one functionalizable atom of said heterocyclic scaffold.  
     
     
         17 . The mixture of  claim 1  wherein at least some of said chemical compounds are subsequently reacted with a further reactant.  
     
     
         18 . The mixture of  claim 17  wherein said further reactant reacts with the heterocyclic portion of the chemical compounds.  
     
     
         19 . The mixture of  claim 1  wherein the heterocyclic portion of said chemical compounds is ring-opened, ring-closed, ring-expanded, bicyclized or altered subsequent to said substitution at said at least one of said functionalizable atoms.  
     
     
         20 . A mixture comprising at least six chemical compounds having a common purine or pyrimidine heterocyclic scaffold, said scaffold having at least two functionalizable atoms, said heterocyclic scaffold being substituted at one of said functionalizable atoms with a set of at least six different chemical substituients optionally connected to said heterocyclic scaffold by a tether moiety; said heterocyclic scaffold being substituted at a second functionalizable atom with the same or a different set of at least six different chemical substituients optionally connected to said heterocyclic scaffold by a tether moiety.  
     
     
         21 . The mixture of  claim 20  wherein at least one of said sets of chemical substituients comprises at least ten species.  
     
     
         22 . The mixture of  claim 20  wherein at least one of said sets of chemical substituients comprise at least fifteen species.  
     
     
         23 . The mixture of  claim 20  wherein at least some of the chemical substituients is connected to said scaffold by tether moieties.  
     
     
         24 . The mixture of  claim 20  wherein said mixture exhibits sensible antibacterial effect.  
     
     
         25 . The mixture of  claim 20  wherein said mixture forms a library having activity against at least one bacterial, viral, nutritional or metabolic disease.  
     
     
         26 . The mixture of  claim 20  wherein said mixture form a library having activity against at least one agricultural pest, household pest, fungus, mold, mildew, or form of decay.  
     
     
         27 . A method for preparing a combinatorial library comprising providing a heterocyclic scaffold molecule having at least two functionalizable atoms; reacting said scaffold with a set of at least six different chemical substituients to append said chemical substituients to the heterocyclic scaffold either directly or, optionally, via a tether moiety.  
     
     
         28 . The method of  claim 27  wherein the chemical compounds of said library are within 20 mole percent of equimolarity.  
     
     
         29 . The method of  claim 27  wherein said reaction is carried out in one reaction apparatus.  
     
     
         30 . The method of  claim 27  performed iteratively.

Join the waitlist — get patent alerts

Track US2002009748A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.